Iya Aleksandrovna Voronkova

Iya Aleksandrovna Voronkova

Auto-generated profile, based on publicly available information

Iya Aleksandrovna Voronkova

Endocrinology Research Centre

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2021 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
AEAnna Eremkina
Anna Eremkina
SMS. S. Mirnaya
S. S. Mirnaya
JKJulia Krupinova
Julia Krupinova
IVI. A. Voronkova
I. A. Voronkova
ПРП. О. Румянцев
П. О. Румянцев
Primary hyperparathyroidism (PHPT) is an endocrine disorder of parathyroid glands characterized by excessive secretion of parathyroid hormone (PTH) with an upper normal or elevated blood calcium level. Classical PHPT refers to a symptomatic, multi-system disorder, wich can lead to a significant decrease in the quality of life, disability of patients, and even an increased risk of premature death. Hypercalcemia and the catabolic effect of PTH on various cells are considered as the main pathogenetic mechanisms of the PHPT associated complications. In the last two decades, there has been an increase in the incidence of PHPT, mainly due to the mild forms of the disease, primarily due to the routine calcium screening in North America, Western Europe and, Asia. High prevalence of the disease, as well as the variety of clinical manifestations, cause the attention of different specialists - physicians, rheumatologists, urologists, nephrologists, cardiologists and other doctors. This review cover the main issues of Russian guidelines for the management of PHPT, approved in 2020, including laboratory and instrumental methods, differential diagnosis, surgical and conservative approach, short-term and long-term follow-up. This guidelines also include the recommendations for special groups of patients with hereditary forms of PHPT, parathyroid carcinoma, PHPT during pregnancy.

29 December 2018 in Endocrine Surgery
Verified
Journal Article
Open access
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
JKJulia Krupinova
Julia Krupinova
IVIya A. Voronkova
Iya A. Voronkova
Parathyroid glands (PG) are endocrine glands, which are the most important humoral regulators of calcium and phosphorus metabolism in the body. They were first described by an Englishman Richard Owen in 1849. Most of patients have four PG – upper and lower. In 13% of cases there are more than four PG. The glands arise as diverticula from the endoderm of the third and fourth branchial pouches between the fifth and twelfth week of gestation. The IV branchial pouch forms the upper gland, and III pouch forms the inferior gland. The parathyroid hormone production has been demonstrated as early as 83/7 weeks gestational age. The formation, migration, differentiation and functioning of the PGs are determined by a number of genes and changes in them could lead to disfunction in these processes. The ectopic of PG is possible when migration violation (up to 22% of cases). The most common location of the ectopic PG is parenchyma of the thymus and thyroid gland. Each PG is richly vascularized and it is surrounded by a thin connective tissue. In adults, there are two types of parenchymal cells: the chief cells (active and inactive forms) and the oxyphil cells. During the life, the ratio of types of parenchymal cells and their activity have been changing, as well as the characteristics of the stroma.

18 June 2018 in Endocrine Surgery
Verified
Journal Article
Open access
PDF file
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
AEAnna Eremkina
Anna Eremkina
KSKonstantin U. Slashchuk
Konstantin U. Slashchuk
ABAlexey I. Bespalov
Alexey I. Bespalov
IVIya А. Voronkova
Iya А. Voronkova
ДВДегтярев Михаил Владимирович
Дегтярев Михаил Владимирович
Primary hyperparathyroidism is common clinical endocrine disorder with a prevalence between 1–2%. Solitary parathyroid adenomas account from 80 to 85% of cases of PHPT, hyperplasia and multiple adenomas is up to 15%, parathyroid carcinoma is a very rare cause of PHPT, accounting for about a 1% of cases. Clinically aggressive and atypical adenomas should be separately noted because of severe clinical course and life-threatening hypercalcemia, high morbidity and mortality, unknown malignant potential. No definite criteria are considered to be present to distinguish preoperatively atypical adenoma from parathyroid typical adenoma or carcinoma. The clinical course of the disease remains the only tool that allows to suspect an aggressive tumor on the preoperative stage. We present the clinical case of a 61-year-old female patient with a clinically “aggressive” course of PHPT and severe metabolic disturbances of bone tissue due to the atypical adenoma of the parathyroid gland.

21 September 2020 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
AEAnna Eremkina
Anna Eremkina
SMSvetlana S. Mirnaya
Svetlana S. Mirnaya
AGAnna Gorbacheva
Anna Gorbacheva
TPTaras Panevin
Taras Panevin
IVIya A. Voronkova
Iya A. Voronkova
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
Osteomalacia is a systemic bone disease, characterized by an excessive accumulation of non-mineralized osteoid and an imbalance in the organic matrix formation and mineralization. A rare cause of disease is tumor-induced osteomalacia, most often due to phosphaturic mesenchymal tumors (PMT). Usually there are benign small tumors, affecting the soft tissues and bones of any location. The basic pathogenesis of underlying oncogenic osteomalacia is a decreased renal tubular reabsorption of phosphate consequent to hyperproduction of fibroblast growth factor 23 in PMT. Clinical features are nonspecific, the average period from the symptoms onset to diagnosis reaches 3 years and at least 5 years before surgical treatment. Finding the tumour is crucial, as complete removal is curative. We present a clinical case of tumor-induced osteomalacia due to PMT required the complex differential diagnosis with other rare diseases.

27 December 2017 in Clinical and experimental thyroidology
Verified
Journal Article
Open access
PDF file
IVIya A. Voronkova
Iya A. Voronkova
ALAnastasiya M. Lapshina
Anastasiya M. Lapshina
LGLarisa E. Gurevich
Larisa E. Gurevich
LRLudmila Ya. Rozhinskaya
Ludmila Ya. Rozhinskaya
TBTimur A. Britvin
Timur A. Britvin
КНКузнецов Сергей Николаевич
Кузнецов Сергей Николаевич
Наиболее часто первичный гиперпаратиреоз (ПГПТ) в сочетании с раком (как правило, медуллярным) щитовидной железы (ЩЖ) встречается при синдромах множественных эндокринных неоплазий. Сочетание немедуллярных карцином ЩЖ и ПГПТ отмечается у 3% пациентов. Доля папиллярного рака (ПР) ЩЖ достигает 87% от всех ее злокачественных опухолей. Атипическая аденома (АА) околощитовидной железы (ОЩЖ) – это новообразование, в котором отсутствуют достоверные признаки инвазивного роста, но есть морфологические критерии, подозрительные в отношении их злокачественного потенциала. Распространенность АА ОЩЖ как причины ПГПТ составляет около 0,5–4%. АА ОЩЖ относятся к опухолям неопределенного злокачественного потенциала. Клиническое значение и отдаленные результаты, а также объем оперативного вмешательства и продолжительность наблюдения за пациентами с АА ОЩЖ из-за редкости опухоли и отсутствия стандартов диагностики данной патологии не определены. В настоящей статье авторы сообщают о двух случаях сочетания АА ОЩЖ и ПР ЩЖ у 63-летней женщины и 57-летнего мужчины. У одного из пациентов, в отличие от второго, были классические симптомы ПГПТ, в том числе тяжелая остеодистрофия и нефропатия. Предоперационный уровень кальция составил 3,48 и 4,1 (2,12–2,6) мкмоль/л, паратиреоидного гормона – 1300 и 1533 (15–65) пг/мл соответственно. В обоих случаях ультразвуковое исследование ЩЖ не выявило достоверно злокачественных новообразований. Рак ЩЖ был заподозрен только во время интраоперационной ревизии, в связи с чем пациентам была проведена тиреоидэктомия и удаление опухоли ОЩЖ. Гистологическое исследование выявило папиллярную микрокарциному ЩЖ (в первом случае одностороннюю, во втором – двустороннюю) и АА ОЩЖ. Большая осведомленность специалистов о сочетании ПРЩЖ с атипической аденомой ОЩЖ позволит расширить настороженность эндокринологов и хирургов, своевременно оценить возможную патологию ЩЖ у пациентов с ПГПТ, тем самым применить адекватный объем вмешательства в ходе одной операции.

12 April 2021 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Open access
PDF file
JKJulia Krupinova
Julia Krupinova
IVIya A. Voronkova
Iya A. Voronkova
AAAlina R. Ajnetdinova
Alina R. Ajnetdinova
AAAleksandr Y. Abrosimov
Aleksandr Y. Abrosimov
IKIrina V. Kryukova
Irina V. Kryukova
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
Background: there are no specific markers of the parathyroid carcinoma (PC) therefore, the development of algorithms for identifying high-risk patients is an urgent task. Aims: to determine the clinical and laboratory predictors of PC and to identify the factors of a poor prognosis. Materials and methods: A multicenter retrospective study included 242 patients with primary hyperparathyroidism (PHPT) who were divided into groups: 162 with adenomas, 30 with аtypical adenomas (АА) and 50 patients with PC. Data collection and analysis was carried out from 2017 to 2020. The primary goal assessment of the possibility of PС using preoperative laboratory and instrumental data. The group of PC was divided into subgroups: the patients in recurrences (n=17) and remission (n=33). The level of the total calcium, albumin, alkaline phosphatase (ALP), ionized calcium (Ca ++) in the blood were determined on the automatic biochemical analyzer; the level of parathyroid hormone (PTH) by electrochemoluminescent analyzer. The size of the PG determined by the ellipse formula: V (cm3) = (A B C) 0.49. Statistical analysis was performed with Statistica 13 and SPSS software packages. For multiple comparisons, the Bonferroni correction was applied. Results: the group of patients with increased risk of PC include persons with increased level of PTH 443 pg/ml, Ca++ 1.5 mmol/l, total calcium 3.2 mmol/l, ALP 176 IU/L, V of tumors 2.6 cm3, largest size 22.5 mm (p 0,001). Heterogeneous structure is more typical to PC compared to the АА (p = 0,004 and р = 0,011), the same applies to indefinite contour (р = 0,001 и р = 0,011). Pathological mitosis is a prognostically unfavorable factor of recurrence of PC (р=0,007). Conclusions: the patients with PC and AA are characterized with more aggressive course of PHPT compared to the group of adenomas.